OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Eric Schon

2 Projects | 1 Researchers | $221,800 Invested

2011

Trustees of Columbia University in the City of New York

Eric Schon, PhD

Mitochondria-associated membranes in the pathogenesis of Alzheimer's disease: a new target for drug discovery

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2009

Trustees of Columbia University in the City of New York

Eric Schon, PhD

Mitochondria-associated membranes in Alzheimer disease: a new target for drug discovery

  • Funding Amount: $121,800
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed